Cargando…

Elevated CXCL1 increases hepatocellular carcinoma aggressiveness and is inhibited by miRNA-200a

In this study, we investigated the value of measurement of the chemokine CXCL1 in clinical management of hepatocellular carcinoma (HCC) and its possible role in the molecular pathogenesis of HCC. High CXCL1 expression predicted recurrence in HCC patients and promoted tumor progression in both in viv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cui, Xiao, Li, Zhao, Gao, Jie, Gao, Peng-Ji, Ni, Yan-bing, Zhu, Ji-Ye
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323138/ https://www.ncbi.nlm.nih.gov/pubmed/27542259 http://dx.doi.org/10.18632/oncotarget.11350

Ejemplares similares

miRNA-101-5p inhibits the growth and aggressiveness of NSCLC cells through targeting CXCL6
por: Chen, Qi, et al.
Publicado: (2019)

Tripterine Restrains the Aggressiveness of Hepatocellular Carcinoma Cell via Regulating miRNA-532-5p/CXCL2 Axis
por: Jiang, Zhi Tao, et al.
Publicado: (2020)

Novel miRNA-31 and miRNA-200a-Mediated Regulation of Retinoblastoma Proliferation
por: Montoya, Vanessa, et al.
Publicado: (2015)

Effects of miRNA-200b on the development of diabetic retinopathy by targeting VEGFA gene
por: Li, En-Hui, et al.
Publicado: (2017)

Members of the miRNA-200 Family Regulate Olfactory Neurogenesis
por: Choi, Philip S., et al.
Publicado: (2008)

MiRNA-200C expression in Fanconi anemia pathway functionally deficient lung cancers
por: Duan, Wenrui, et al.
Publicado: (2021)

miR200-regulated CXCL12β promotes fibroblast heterogeneity and immunosuppression in ovarian cancers
por: Givel, Anne-Marie, et al.
Publicado: (2018)

Serum exosomal miRNA-145 and miRNA-200c as promising biomarkers for preoperative diagnosis of ovarian carcinomas
por: Kim, Sewha, et al.
Publicado: (2019)

Systematic large-scale meta-analysis identifies miRNA-429/200a/b and miRNA-141/200c clusters as biomarkers for necrotizing enterocolitis in newborn
por: Liu, Hong, et al.
Publicado: (2019)

Elevated expression of CXCL16 correlates with poor prognosis in patients with colorectal cancer
por: Chen, Zhihui, et al.
Publicado: (2019)

MiR200-upregulated Vasohibin 2 promotes the malignant transformation of tumors by inducing epithelial-mesenchymal transition in hepatocellular carcinoma
por: Xue, Xiaofeng, et al.
Publicado: (2014)

MiRNA-22 inhibits oncogene galectin-1 in hepatocellular carcinoma
por: You, Yu, et al.
Publicado: (2016)

miRNA‐215‐5p suppresses the aggressiveness of breast cancer cells by targeting Sox9
por: Gao, Jia Bao, et al.
Publicado: (2019)

Mechanisms and Functions of MiR-200 Family in Hepatocellular Carcinoma
por: Mao, Yinqi, et al.
Publicado: (2021)

Overexpression of CXCL2 inhibits cell proliferation and promotes apoptosis in hepatocellular carcinoma
por: Ding, Jun, et al.
Publicado: (2018)

Diagnostic performance of serum exosomal miRNA-720 in hepatocellular carcinoma
por: Jang, Jeong Won, et al.
Publicado: (2022)

Little things with significant impact: miRNAs in hepatocellular carcinoma
por: Li, Jiehan, et al.
Publicado: (2023)

The miRNA-200 family and miRNA-9 exhibit differential expression in primary versus corresponding metastatic tissue in breast cancer
por: Gravgaard, KH, et al.
Publicado: (2011)

Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers
por: Cochrane, Dawn R., et al.
Publicado: (2010)

A MiRNA Signature for Defining Aggressive Phenotype and Prognosis in Gliomas
por: Barbano, Raffaela, et al.
Publicado: (2014)

The heterogeneity of plasma miRNA profiles in hepatocellular carcinoma patients and the exploration of diagnostic circulating miRNAs for hepatocellular carcinoma
por: Bai, Xue, et al.
Publicado: (2019)

miRNA-200c-3p is crucial in acute respiratory distress syndrome
por: Liu, Qiang, et al.
Publicado: (2017)

Upregulation of miRNA-200c during Disease Progression in COVID-19 Patients
por: van de Sand, Lukas, et al.
Publicado: (2022)

Evaluation of miRNA-7, miRNA-10 and miRNA-21 as diagnostic non-invasive biomarkers of hepatocellular carcinoma
por: Elabd, Walaa K., et al.
Publicado: (2023)

CXCL13, CXCL10 and CXCL8 as Potential Biomarkers for the Diagnosis of Neurosyphilis Patients
por: Wang, Cuini, et al.
Publicado: (2016)

miR‐200c suppresses stemness and increases cellular sensitivity to trastuzumab in HER2+ breast cancer
por: Tang, Hailin, et al.
Publicado: (2019)

Role of miR200b-5p miRNA in lymphomagenesis associated with Sjögren’s syndrome (SS)
por: Kapsogeorgou, Efstathia K., et al.
Publicado: (2018)

MiRNA-186-5p Exerts an Anticancer Role in Breast Cancer by Downregulating CXCL13
por: Wang, Yulong, et al.
Publicado: (2022)

MiRNA-141 and miRNA-200b are closely related to invasive ability and considered as decision-making biomarkers for the extent of PLND during cystectomy
por: Liu, Wentao, et al.
Publicado: (2015)

miRNA-200a/c as potential biomarker in epithelial ovarian cancer (EOC): evidence based on miRNA meta-signature and clinical investigations
por: Teng, Yue, et al.
Publicado: (2016)

MiRNA-200b Regulates RMP7-Induced Increases in Blood-Tumor Barrier Permeability by Targeting RhoA and ROCKII
por: Ma, Teng, et al.
Publicado: (2016)

CXCL13 Promotes Osteogenic Differentiation of Mesenchymal Stem Cells by Inhibiting miR-23a Expression
por: Tian, Feng, et al.
Publicado: (2015)

Combating Drug Resistance by Exploiting miRNA-200c-Controlled Phase II Detoxification
por: Köhler, Bianca, et al.
Publicado: (2022)

The Roles of miRNA in Glioblastoma Tumor Cell Communication: Diplomatic and Aggressive Negotiations
por: Buruiană, Andrei, et al.
Publicado: (2020)

Plasma Exosome miRNAs Profile in Patients With ST-Segment Elevation Myocardial Infarction
por: Guan, Ruicong, et al.
Publicado: (2022)

Adipogenic miRNA and meta-signature miRNAs involved in human adipocyte differentiation and obesity
por: Shi, Chunmei, et al.
Publicado: (2016)

Potential plasma biomarkers: miRNA-29c, miRNA-21, and miRNA-155 in clinical progression of Hepatocellular Carcinoma patients
por: Ratnasari, Neneng, et al.
Publicado: (2022)

Identification of miRNA-34a and miRNA-155 as prognostic markers for mantle cell lymphoma
por: He, Jianxia, et al.
Publicado: (2021)

A miRNA Combination as Promising Biomarker for Hepatocellular Carcinoma Diagnosis: A Study Based on Bioinformatics Analysis
por: Ji, Jia, et al.
Publicado: (2018)

Chemokine (C-X-C) ligand 1 (CXCL1) protein expression is increased in aggressive bladder cancers
por: Miyake, Makito, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_qbqkdnur6io6cbiceung812i3r